Navigation Links
Bionovo Announces 2010 Highlights and Year-End Financial Results
Date:3/15/2011

s.

As of December 31, 2010, cash, cash equivalents and short-term investments totaled approximately $2.6 million compared to $15.9 million at December 31, 2009. The decrease is due to the public offering completed in October of 2009 resulting in net proceeds of $17.4 million, whereas the public offering completed in October 2010 generated net proceeds of $2.5 million. The net cash used in operating activities for 2010 was $14.2 million, compared with $13.3 million in 2009.

2011 GuidanceOn February 10th, the Company laid out key milestones for 2011, which are reiterated here:Manufacture of drug material at higher potency for clinical and non-clinical testing.

Early first quarter. Completed.Conduct a 40 patient, 28-day "tolerability" trial at higher doses planned for later studies.

Late first quarter, early second quarter.Non-clinical study for toxicity in rodents.

Late first quarter, early second quarter.Manufacture of clinical material for Phase 3 study, using FDA-approved commercial process.

Second quarter.Complete contracts, IRB approval and training at U.S. clinical sites for the Phase 3 study.

First and second quarter.Initiate patient recruitment and screening in the Phase 3 study.

End of the second quarter.Initiate dosing in the Phase 3 study.

Early in the third quarter.Data Safety Monitoring Board interim reviews of Phase 3 data.

Five reviews are planned during the course of the Phase 3 study.Completion of recruitment for the Phase 3 study.

Anticipated by the end of the second quarter, 2012.Data available from the Phase 3 study.

Anticipated by the end of the fourth quarter, 2012.Conference CallBionovo will conduct a conference call and webcast to review the Company's financial results and plans for 2011. Interested parties can access the call by dialing 1-888-428-7458, or can listen via a live audio only webcast, which can be found at '/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
2. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
3. Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
4. Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants
5. Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors
6. Bionovo Releases FDA-Approved Clinical Development Plan for Menerba
7. Bionovo Announces Publication Describing Estrogen Receptor Beta Cancer Prevention Mechanism
8. Bionovo Announces Third Quarter 2010 Highlights and Financial Results
9. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2010 Financial Results on Thursday, November 11, 2010
10. Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
11. Bionovo to Raise $3 Million Through Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Tobramycin ... Tobramycin is a traditional antibiotic whose eye drop and ... treatment of potential infection or inflammation caused by eye ... are able to produce tobramycin, among which ...
(Date:8/28/2015)... , Aug. 28, 2015 Patterson Medical, ... (Nasdaq: PDCO ), is now an independent ... acquisition of Patterson Medical by Madison Dearborn Partners ... its name for a transition period before rebranding ... and sports medicine products.  With the focused resources ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... to their offering. Developed by Novo ... Novolog) is an important drug for the treatment ... as a fast- acting insulin analog, starts working ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... , MT. LAUREL, N.J., Dec. 1 ... of technology-enabled clinical documentation services, today announced that the radiology ... SpeechQ for Radiology(TM), MedQuist,s real-time speech recognition system. The solution ... (RSNA) convention November 29 through December 2. ...
... , PISCATAWAY, N.J., Dec. 1 Siemens ... hearing instruments, announced its third annual partnership with Quota International,s ... 2010. , As part of the renewed partnership, Siemens is ... instruments to both children and young adults, age 23 years ...
Cached Medicine Technology:MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3
(Date:8/28/2015)... ... 28, 2015 , ... “ Frequentz ” was featured on NewsWatch as part ... on the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch ... allows businesses to track product movement from beginning to end. , Businesses benefit greatly ...
(Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s largest travel ... in Healthcare by Modern Healthcare and will be honored at an awards dinner ... year, the Best Places to Work in Healthcare program recognizes outstanding employers in the ...
(Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, D.C., ... pain resulting in shoulder pain, hip pain, neck pain, stiffness, muscle spasms, ... from the University of Illinois, and then went on to earn his title of ...
(Date:8/28/2015)... ... ... Northridge dentists Dr. Elyson and Dr. Assili are now offering ... receive a one hour treatment of this teeth whitening option. Zoom whitening ... unique features that can turn teeth up to nine shades whiter. Effective on a ...
(Date:8/28/2015)... Ca (PRWEB) , ... August 28, 2015 , ... ... administering medical evaluations for those seeking to go deep sea diving. The ... oxygen toxicity, and decompression sickness; for these reasons, it is vital that all ...
Breaking Medicine News(10 mins):Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Healthpointe Now Offering Scuba Physicals 2
... ,A new study hints at one reason that black Americans are ... Blacks appear to have higher levels of a certain type of ... standard screening. This so-called "non-calcified plaque" -- which consists of ... can rupture and send out blood clots that can lead to ...
... nurses doubt that a clinical neurological examination can establish that ... that this uncertainty can affect relatives when the question of ... the Sahlgrenska Academy, University of Gothenburg, Sweden. End-of-life ... for patients who are brain dead and who by their ...
... weigh less than their non-consuming counterparts, according to a new ... a peer-reviewed journal. This is potentially important ... But lead researcher Carol O,Neil, PhD, MPH, LDN, RD, Louisiana ... put into perspective. "The study illustrates that children ...
... The process of cell division is tightly regulated, as mistakes ... fingered as causing tumors in both skin and liver. ... Medicine, Vienna, has now uncovered a surprising detail with the ... an important anti-tumor factor. The results have recently been ...
... , TUESDAY, June 28 (HealthDay News) -- A flexible work ... their jobs after giving birth, according to a new study. ... flexible schedule provides working moms with alternatives for meeting those ... better able to control their work environment and adapt, work-related ...
... may have discovered one reason that African Americans are at ... According to a new study published online in the ... non-calcified plaque, which consists of buildups of soft deposits deep ... by some cardiac tests. Non-calcified plaque is more vulnerable to ...
Cached Medicine News:Health News:Study Hints at Why Heart Disease Is More Deadly for Blacks 2Health News:Intensive care nurses have doubts about method for establishing brain death 2Health News:Intensive care nurses have doubts about method for establishing brain death 3Health News:New study shows children and adolescents who eat candy are less overweight or obese 2Health News:The good, the bad and the ugly: The many roles of c-JUN in cancer 2Health News:Flexible Schedule Helps Keep New Moms in the Workplace 2Health News:CT angiography improves detection of heart disease in African-Americans 2
Welch Allyn introduced halogen HPX lamp technology to provide 30% more light output than previous halogen lamps. The mix of halogen and xenon gases provide whiter, longer lasting light - making your ...
RT-600 Refractor...
... Ultramatic Rx Master is designed ... of reliable service and give ... measurably improve procedures. It embodies ... and want most, including accuracy, ...
Occluder and Maddox Rod...
Medicine Products: